Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Step Therapy Legislation in the States: Navigating a Varied & Complex System

Joseph Cantrell, JD  |  July 17, 2019

As the practice of step therapy grows more pervasive throughout the insurance industry, the protocols become increasingly confusing to navigate. Steps vary from insurer to insurer based on plan type, and formulary differences are too often based on economic incentives rather than outcome-based medicine. Patients are often left hanging in the balance while physicians’ offices help them navigate the step therapy process.

Fortunately, states are now stepping in to help bring some uniformity to the insurance market. Twenty-four states have now passed some variation of step therapy reform. If there’s one word to characterize step therapy practices nationwide, it would be “variable.” Even though states pass reform, physicians may not even notice a difference. Medicare and Employee Retirement Income Security Act (ERISA) based plans are exempt from state reforms because states cannot preempt the federal laws that govern these programs. That is why it is important for you to contact your Congress members and Senators to encourage them to support a federal step therapy bill. You can easily do this through the ACR’s Legislative Action Center.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Only Connecticut, Kansas, Louisiana, New Mexico, New York and Wisconsin have included Medicaid plans in their step therapy reform packages. What about the other components of reform? Here is a brief rundown of where the states stand and how to navigate your state’s step therapy framework.

24-Hour Emergency Response to Override Request
The 24-hour emergency response to an override request is critically important to patients who need rapid treatment. More timely interventions can mean better outcomes for patients, but that requires state policy that recognizes that fact and respects the physician’s right to choose the best drug for the patient.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Nationwide step therapy practices are variable. Only 10 states currently have a 24-hour emergency response to override requirement. Illinois, Indiana, Kansas, New Mexico, New York, Texas and Virginia currently have this provision effective. The Georgia, Oklahoma and Wisconsin provisions will go into effect on Jan. 1, 2020. Washington’s provision will go into effect in January 2021.

Also of note, Ohio has a 48-hour emergency response requirement that will go into effect on Jan. 1, 2020, while Iowa and Minnesota both have a 72-hour emergency response requirement. Although these offer some protections for patients, these are not ideal timelines for emergency cases.

72-Hour or Better Response to General Override Requests
The 72-hour response requirement for general override requests is critical for getting all patients access to the care they deserve. Right now, only 13 states have this requirement. Arkansas, California, Illinois, Indiana, Kansas, New Mexico, New York, Texas and Virginia all have the 72-hour response requirement in effect. Georgia, Oklahoma, and Wisconsin will have this provision effective starting Jan. 1, 2020, while Washington’s will go into effect in January 2021.

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & Advocacy Tagged with:overridestep therapy state legislation

Related Articles

    State Step Therapy Laws: Not All Are Created Equal

    April 8, 2019

    Step therapy reform has been a hot topic and major focus of the ACR’s advocacy activity in states this legislative session. Washington, Oregon, Wisconsin and Florida are all considering step therapy bills that stand good chance of passing this legislative year. Virginia and Georgia have already passed step therapy laws. When these two new laws…

    The 21st Century Cures Act Information-Blocking Rule

    April 17, 2021

    The 21st Century Cures Act (Cures Act) became law on Dec. 13, 2016, and emphasized interoperability in the exchange of healthcare information between healthcare providers, health information entities and patients. The Cures Act underscored unimpeded access to patient electronic health information (EHI) upon request, in a manner that is secure and updated automatically, and prohibits…

    The ACR and Partners Help Get Legislation Passed in New York to Limit Step Therapy

    August 4, 2016

    In June, state lawmakers in New York passed legislation on step therapy designed to help ensure patient access to the best and most appropriate care. Step therapy mandates that a patient with a specific condition receive prescribed drugs approved for that condition in the order that an insurance company determines it will cover as the…

    Drug UPDATES

    March 18, 2011

    Information on New Approvals and Medication Safety

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences